Atherton, CA, United States of America

Aimee Brigitte Angel


Average Co-Inventor Count = 2.3

ph-index = 9

Forward Citations = 762(Granted Patents)


Company Filing History:


Years Active: 2005-2012

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Aimee Brigitte Angel: Innovator in Transdermal Transport Technology

Introduction

Aimee Brigitte Angel is a prominent inventor based in Atherton, CA (US). She has made significant contributions to the field of transdermal transport devices, holding a total of 9 patents. Her innovative work focuses on enhancing the delivery of active principles through the skin, which has important implications for medical treatments.

Latest Patents

Among her latest patents is the Microneedle Transdermal Transport Device. This device features a reservoir for holding a formulation of an active principle and a needle with a bore extending along its length. The design ensures that the second end of the needle aligns with a plane parallel to the body surface when placed on it. An actuator is included to pump the formulation through the needle's bore, facilitating targeted delivery. Another notable patent is the Microneedle Transport Device, which consists of an array of needles in fluid communication with the reservoir. This device allows for efficient transport of the formulation to and from the reservoir, with actuators that drive the needles into the body and pump the formulation as needed.

Career Highlights

Aimee has worked with prestigious institutions such as the Massachusetts Institute of Technology and Stanford University. Her experience in these renowned organizations has contributed to her expertise in the development of innovative medical devices.

Collaborations

Aimee has collaborated with notable colleagues, including Ian W. Hunter and Laura L. Proctor. Their combined efforts have advanced the field of transdermal delivery systems.

Conclusion

Aimee Brigitte Angel is a trailblazer in the realm of transdermal transport technology. Her patents and collaborations reflect her commitment to innovation and improving medical treatments through advanced delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…